Capital International Sarl Acquires 5,859 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Capital International Sarl lifted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 6.9% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 90,485 shares of the medical equipment provider's stock after buying an additional 5,859 shares during the period. Intuitive Surgical comprises 1.1% of Capital International Sarl's investment portfolio, making the stock its 22nd biggest holding. Capital International Sarl's holdings in Intuitive Surgical were worth $47,230,000 as of its most recent SEC filing.

Other institutional investors also recently made changes to their positions in the company. Atala Financial Inc purchased a new position in Intuitive Surgical during the 4th quarter valued at about $25,000. Berbice Capital Management LLC acquired a new position in shares of Intuitive Surgical during the 4th quarter valued at about $26,000. BankPlus Trust Department acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at $28,000. Hurley Capital LLC purchased a new position in shares of Intuitive Surgical in the 4th quarter worth about $28,000. Finally, Summit Securities Group LLC acquired a new stake in shares of Intuitive Surgical in the fourth quarter worth $30,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG traded up $1.40 during midday trading on Friday, reaching $482.74. The company's stock had a trading volume of 1,618,989 shares, compared to its average volume of 1,589,481. The firm has a market capitalization of $171.94 billion, a price-to-earnings ratio of 75.31, a PEG ratio of 5.85 and a beta of 1.55. Intuitive Surgical, Inc. has a fifty-two week low of $364.31 and a fifty-two week high of $616.00. The firm has a 50 day moving average price of $522.23 and a two-hundred day moving average price of $532.71.

Analyst Ratings Changes

A number of analysts recently weighed in on the stock. Barclays upped their price target on shares of Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. Raymond James boosted their target price on Intuitive Surgical from $560.00 to $688.00 and gave the stock an "outperform" rating in a research report on Friday, January 24th. Royal Bank of Canada upped their price target on shares of Intuitive Surgical from $611.00 to $641.00 in a research note on Monday, January 27th. Erste Group Bank lowered Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a research note on Monday, March 17th. Finally, BTIG Research set a $560.00 price objective on shares of Intuitive Surgical and gave the stock a "buy" rating in a report on Monday, April 14th. One analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have issued a buy rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $611.81.

Insider Buying and Selling at Intuitive Surgical

In related news, CFO Jamie Samath sold 94 shares of the firm's stock in a transaction dated Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total transaction of $53,684.34. Following the transaction, the chief financial officer now directly owns 2,630 shares of the company's stock, valued at $1,502,019.30. This trade represents a 3.45 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Robert Desantis sold 11,545 shares of the stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the completion of the sale, the executive vice president now owns 5,224 shares of the company's stock, valued at approximately $2,607,925.28. This trade represents a 68.85 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 33,754 shares of company stock valued at $17,691,621. Corporate insiders own 0.70% of the company's stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.